awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47095307-3E0F8BCD-5A70-4406-ADD8-84DE2BA387A3
Q47095307-3E0F8BCD-5A70-4406-ADD8-84DE2BA387A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47095307-3E0F8BCD-5A70-4406-ADD8-84DE2BA387A3
A Bayesian pick-the-winner design in a randomized phase II clinical trial.
P2860
Q47095307-3E0F8BCD-5A70-4406-ADD8-84DE2BA387A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47095307-3E0F8BCD-5A70-4406-ADD8-84DE2BA387A3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9148e0e50a61b1f204c0eafa64957dc862aac1d8
P2860
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.